β受体阻断剂倍他乐克对对脓毒症休克患者心肌损伤BNP水平的影响(2)
 |
| 第1页 |
参见附件(2763KB，2页)。
参考文献
[1] 常锦雄，温端改.感染性休克治疗新进展.内科急危重症杂志.1995,5:130
[2] Waisbren BA. Bacteremia due to gram-negative bacilli other than the Salmonella:a cilinical and therapeutic study . AMAArch Intern Med, 1951,88:467
[3] Flierl MA,Rittirch D, Huber-Lang MS,et al .Molecular Events in the Cardiomyopathy of sepsis . Mol Med, 2008,14:327
[4] Mueller C, Scholer A，Laule-Kilian K， et al:Use of B-type natriuretic peptide in the evalution and mangement of acute dyspnea. N Engl J Med . 2004, 350:647-654
[5] 徐敏， 夏仲芳，耿平，等. 4CD-(62P)和TpP对严重脓毒血症高宁状态的早期诊断价值[J].
[6] Mclean D ,Tang B, Nalos M , et al : Increased B-type natriuretic peptide(BNP) is a strong predictor for cardic dysfunction in intensive care unit patients, Anaesh Intensive Care ,2003,31:21-27
[7] Charpentier J, Luyt C-E, Fulla Y,et al:Brain natriuretic peptide :A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med, 2004,32:660-665
[8] 刘大为，邱海波. β受体阻断剂在全身性感染和感染性休克治疗中的应用 .重症医学 .2010：73-75
[9] Wittllaut R , Busch C, Frallnberger P,et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock : Impact of interleukin-6 and seosis associated left ventricular dysfunction. Intensive Care Med, 2003,29;1696-1072
您现在查看是摘要介绍页，详见PDF附件(2763KB，2页)。